Close

Form 8-K U S PHYSICAL THERAPY For: Aug 06

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY
6. BA
7. HCP
8. SNAP
9. TMUS
10. BSX


August 6, 2015 8:36 AM EDT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 
 
FORM 8-K

 
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): August 6, 2015 (August 6, 2015)


 
U.S. PHYSICAL THERAPY, INC.
(Exact name of registrant as specified in its charter)
 
Nevada
  
1-11151
  
76-0364866
(State or other jurisdiction
of incorporation or organization)
  
(Commission
File Number)
  
(I.R.S. Employer
Identification No.)
 
1300 West Sam Houston Parkway South,
Suite 300, Houston, Texas
  
77042
(Address of Principal Executive Offices)
  
(Zip Code)
 
Registrant’s telephone number, including area code: (713) 297-7000
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):
 
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨
Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))
 
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
 
ITEM 2.02
RESULTS OF OPERATIONS AND FINANCIAL RESULTS
 
On August 6, 2015, U.S. Physical Therapy, Inc. (the “Company”) reported its results for the second quarter and six months ended June 30, 2015 and will hold a conference call with investors at 9:30 Central Time on August 6. During the conference call, Adjusted EBITDA, a non-GAAP financial measure, for the trailing twelve months ended June 30, 2015 will be discussed.
 
The following table reconciles adjusted net income attributable to common shareholders, the most directly comparable financial measure calculated and presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”), to Adjusted EBITDA. Management believes providing Adjusted EBITDA to investors is useful information for comparing the Company’s period-to-period results.  Adjusted EBITDA is defined as earnings before interest, taxes, depreciation, amortization and equity compensation expense.
 
Adjusted EBITDA is not a measure of financial performance under GAAP. Items used to compute Adjusted EBITDA are significant components in understanding and assessing financial performance. Adjusted EBITDA should not be considered in isolation or as an alternative to, or substitute for, net income attributable to common shareholders or net income including noncontrolling interests data presented in the consolidated financial statements as indicators of financial performance. Because Adjusted EBITDA is not a measurement determined in accordance with GAAP, and is thus susceptible to varying calculations, this measurement may not be comparable to other similarly titled measures of other companies.
 
For the trailing twelve months ended June 30, 2015 (in thousands):      
       
Net revenues
   $ 317,635  
         
Net income attributable to U. S. Physical Therapy, Inc.
     20,663  
         
Adjustments:
        
Depreciation and amortization
     7,589  
Interest, net (income) / expense
     972  
Noncontrolling interests
     9,286  
Equity grant expense
     3,976  
Provision for income taxes
     13,846  
         
Adjusted EBITDA from operations including noncontrolling interests
     56,332  
         
Noncontrolling interests
     (9,286 )
         
Adjusted EBITDA
   $ 47,046  
 
In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

ITEM 9.01
FINANCIAL STATEMENTS AND EXHIBITS
 
Exhibits
  
Description of Exhibits
  
       
None
  
    
 
 
 
 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
U.S. PHYSICAL THERAPY, INC.
     
Dated: August 6, 2015
By:
/s/ LAWRANCE W. MCAFEE
   
Lawrance W. McAfee
   
Chief Financial Officer
   
(duly authorized officer and principal financial
           and accounting officer)

3

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings